Zoetis Inc. Line of Credit Facility, Maximum Borrowing Capacity
Zoetis Inc. (ZTS) had Line of Credit Facility, Maximum Borrowing Capacity of $46.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2026-08-06
- 2026-06-30: Line of Credit Facility, Maximum Borrowing Capacity $46.00M.
- 2026-03-31: Line of Credit Facility, Maximum Borrowing Capacity $47.00M.
- 2025-12-31: Line of Credit Facility, Maximum Borrowing Capacity $51.00M.
- 2025-09-30: Line of Credit Facility, Maximum Borrowing Capacity $60.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2026-06-30 | $46.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $47.00M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $51.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $60.00M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $53.00M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $51.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $50.00M 10-K · filed 2025-02-13 |
| 2024-09-30 | $56.00M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $55.00M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $60.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $56.00M 10-K · filed 2024-02-13 |
| 2023-09-30 | $50.00M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $52.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $51.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $51.00M 10-K · filed 2023-02-14 |
| 2022-09-30 | $50.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $51.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $64.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $63.00M 10-K · filed 2022-02-15 |
| 2021-09-30 | $71.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $79.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $80.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $79.00M 10-K · filed 2021-02-16 |
| 2020-09-30 | $77.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $75.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $75.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $76.00M 10-K · filed 2020-02-13 |
| 2019-09-30 | $76.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $73.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $73.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $77.00M 10-K · filed 2019-02-14 |
| 2018-09-30 | $75.00M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $61.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $71.00M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $75.00M 10-K · filed 2018-02-15 |
| 2017-10-01 | $77.00M 10-Q · filed 2017-11-02 |
| 2017-07-02 | $75.00M 10-Q · filed 2017-08-08 |
| 2017-04-02 | $75.00M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $75.00M 10-K · filed 2017-02-16 |
| 2016-10-02 | $81.00M 10-Q · filed 2016-11-03 |
| 2016-07-03 | $91.00M 10-Q · filed 2016-08-05 |
| 2016-04-03 | $91.00M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $79.00M 10-K · filed 2016-02-24 |
| 2015-09-27 | $79.00M 10-Q · filed 2015-11-05 |
| 2015-06-28 | $82.00M 10-Q · filed 2015-08-06 |
| 2015-03-29 | $68.00M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $74.00M 10-K · filed 2015-02-27 |
| 2014-09-28 | $73.00M 10-Q · filed 2014-11-10 |
| 2014-06-29 | $61.00M 10-Q · filed 2014-08-12 |
| 2014-03-30 | $67.00M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $69.00M 10-K · filed 2014-03-26 |
| 2013-09-29 | $125.00M 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |